Chronic kidney disease (CKD) affects 844 million adults globally, yet 30% to 50% of cases remain undiagnosed in high-income countries, according to a series of papers published in The Lancet. Researchers from the University of Glasgow report that the disease is currently the ninth leading cause of death worldwide and is projected to become the fifth by 2040.
Closing the Diagnosis Gap with Routine Screening
CKD often progresses silently. Most patients experience no symptoms until the disease reaches an advanced stage, which frequently necessitates a kidney transplant or dialysis. To counter this, University of Glasgow researchers advocate for the wider use of simple urine tests to detect protein.
When combined with blood pressure checks and blood tests that measure kidney function, these screenings can identify the disease early. According to the Lancet papers, early diagnosis allows for timely interventions that can slow or entirely prevent the progression of kidney disease.
Did you know? CKD is often a “silent” condition. You might feel perfectly healthy while your kidney function is declining, making routine screening a way to catch it early.
High-Risk Groups and Diagnostic Disparities
Not all populations are diagnosed at the same rate. The Lancet series highlights significant disparities, noting that women and people from non-white ethnic groups are more likely to remain undiagnosed. Even in cases where medical records indicate a patient has CKD, many individuals remain unaware of their condition.
The risk of developing CKD increases with age. However, researchers identified leading risk factors:
- Diabetes
- Hypertension (High blood pressure)
- Obesity
- Cardiovascular disease
Global Healthcare Infrastructure and Future Trends
The proportion of undiagnosed cases is likely to be much higher in low- and middle-income nations due to limited access to diagnostic services. The authors of the research call for increased investment in laboratory capacity and healthcare systems to bridge this gap.
The Lancet papers review several advancements that could change patient outcomes, including:
- Improved Biomarkers: Indicators to catch kidney stress earlier.
- Genetic Testing: Identifying predispositions to kidney failure.
- Newer Therapies: The development of drugs that delay disease progression when administered in the early stages.
Pro Tip: If you have diabetes or hypertension, ask your doctor about screening for CKD.
Frequently Asked Questions
What is the most effective way to detect CKD early?
According to researchers from the University of Glasgow, routine urine tests for protein, blood pressure checks, and blood tests measuring kidney function can help detect the disease early.
Who is at the highest risk for kidney disease?
The leading risk factors include diabetes, hypertension, obesity, and cardiovascular disease, with risk increasing as a person ages.
Why is CKD often undiagnosed?
The disease is progressive and typically lacks noticeable symptoms until it reaches an advanced stage, leading to a diagnosis gap of 30% to 50% even in wealthy nations.
Want to stay informed on the latest medical research? Share your thoughts in the comments below or subscribe to our health newsletter for deep dives into the latest clinical findings.
Related reading